{"abstract": "Royalty Pharma sweetened its offer on Monday for Elan, the Irish drug company, on the same day that Elan announced two acquisitions, a spinoff, a share buyback and an $800 million bond issue as it sought to fend off the takeover attempt.", "web_url": "https://dealbook.nytimes.com/2013/05/20/royalty-pharma-raises-bid-for-a-resistant-elan/", "snippet": "Royalty Pharma sweetened its offer on Monday for Elan, the Irish drug company, on the same day that Elan announced two acquisitions, a spinoff, a share buyback and an $800 million bond issue as it sought to fend off the takeover attempt.", "lead_paragraph": "4:03 p.m. | Updated ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Royalty Pharma Raises Bid for a Resistant Elan", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Elan Corporation PLC", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Royalty Pharma", "rank": 3, "major": "N"}], "pub_date": "2013-05-20T17:24:14+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Julia Werdigier", "person": [{"firstname": "Julia", "middlename": null, "lastname": "Werdigier", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/5e1c21b1-f319-52fe-937d-0cf978425421", "word_count": 627, "uri": "nyt://article/5e1c21b1-f319-52fe-937d-0cf978425421"}